DPYD and gastric neoplasm: Gastric tumors with high expression levels of TS or DPD are thought to be capable of responding to S-1 alone, whereas doublet treatment (such as capecitabine with oxaliplatin) would be required for patients with low tumoral expression levels of TS or DPD, since these individuals have a poor prognosis after S-1 treatment alone.